Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul 15;30(14):1305-9.
doi: 10.1089/neu.2012.2815. Epub 2013 Jul 11.

MRI biomarkers for post-traumatic epileptogenesis

Affiliations

MRI biomarkers for post-traumatic epileptogenesis

Riikka Immonen et al. J Neurotrauma. .

Abstract

The present study tested a hypothesis that early identification of injury severity with quantitative magnetic resonance imaging (MRI) provides biomarkers for predicting increased seizure susceptibility and epileptogenesis after traumatic brain injury (TBI). TBI was induced by lateral fluid percussion injury (FPI) in adult rats. Quantitative T2, T1ρ, and diffusion were assessed with MRI at 9 days, 23 days, or 2 months post-TBI in the perilesional cortex, thalamus, and hippocampus. Seizure susceptibility was assessed at 12 months after TBI using the pentylenetetrazol seizure-susceptibility test. At 9 and 23 days post-TBI, a change in T1ρ of the perilesional cortex showed the greatest predictive value for increased seizure susceptibility at 12 months post-TBI [area under the curve (AUC), 0.929 and 0.952, respectively; p<0.01]. At 2 months post-TBI, Dav in the thalamus was the best of the biomarkers analyzed (AUC, 0.988; p<0.05). The highest predictive value of all biomarkers was achieved by combining the measurement of Dav in the perilesional cortex and the thalamus at 2 months post-TBI (AUC, 1.000; p<0.01). Our results provide proof-of-concept evidence that clinically relevant MRI biomarkers predict increased seizure susceptibility after experimental TBI.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Coronal slice from the center of the brain after lateral fluid-percussion–induced traumatic brain injury (TBI), imaged at 23 days post-TBI. (A) A T2-weighted image is shown. Dashed outlines show the regions of interest: (1) somatosensory cortex (S1); (2) dorsal perilesional cortex; (3) ventral perilesional cortex; and (4) perirhinal cortex (PRh). Scale bar=1 mm. (B) T1ρ, (C) T2, and (D) Dav maps from the same location (slice thickness, 1.5 mm) displaying increased relaxation and diffusion values in the perilesional cortex as well as abnormal values within the thalamus ipsilateral to the injury. (E) Results of the pentylenetetrazol (PTZ) seizure-susceptibility test at 12 months post-TBI. As outcomes, we assessed (1) the number of spikes (left panel) and (2) the number of epileptiform discharges (middle panel) during the first 60 min after PTZ injection, as well as (3) the latency to the first epileptiform spike after PTZ injection (right panel). From these, the number of spikes/60 min was chosen to divide animals into increased (iSS) or unchanged (uSS) seizure-susceptibility groups in the ROC analysis because it showed the lowest variation among control animals. Consequently, rats with a spike number higher than the mean+1 standard deviation in controls (>77 spikes/60 min) were considered as animals with iSS (epileptogenic) and those with <77 spikes/60 min as rats with uSS (nonepileptogenic). The number of spikes and number of epileptiform discharges were higher in the TBI group, as compared to controls (*p<0.05). Color image is available online at www.liebertpub.com/neu
FIG. 2.
FIG. 2.
Summary of receiver operating characteristic (ROC) for parameters assessed at 9 days, 23 days, or 2 months postinjury, which predicted increased seizure susceptibility (iSS) at 12 months post-TBI (traumatic brain injury). A diagonal line represents 50% probability for correct prognosis. Area under the curve (AUC) and sensitivity at 100% or 90% specificity are shown in Supplementary Table 1 (see online supplementary material at http://www.liebertpub.com).

References

    1. Yue L. Yu P.M. Zhao D.H. Wu D.Y. Zhu G.X. Wu X.Y. Hong Z. Determinants of quality of life in people with epilepsy and their gender differences. Epilepsy Behav. 2011;22:692–696. - PubMed
    1. Baulac M. Pitkänen A. Research priorities in epilepsy for the next decade—a representative view of the European scientific community. Epilepsia. 2009;50:571–578.
    1. Kelley M.S. Jacobs M.P. Lowenstein D.H. NINDS Epilepsy Benchmark Stewards. The NINDS epilepsy research benchmarks. Epilepsia. 2009;50:579–582. - PMC - PubMed
    1. Hauser W.A. Annegers J.F. Kurland L.T. Prevalence of epilepsy in Rochester, Minnesota: 1940–1980. Epilepsia. 1991;32:429–445. - PubMed
    1. Annegers J.F. Hauser W.A. Coan S.P. Rocca W.A. A population-based study of seizures after traumatic brain injuries. N. Engl. J. Med. 1998;338:20–24. - PubMed

Publication types